Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.43487 | 17 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.41954 | 17 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.42299 | 17 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.36635 | 17 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.36432 | 17 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.47237 | 17 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.42086 | 16 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.3978 | 17 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.39533 | 17 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.39257 | 16 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.40593 | 17 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.36403 | 16 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.41505 | 17 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.41105 | 17 |